Abilify and Entyvio drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abilify (aripiprazole) and Entyvio (vedolizumab). Common drug interactions include blood creatine phosphokinase increased among females and pancreatic carcinoma among males.

The phase IV clinical study analyzes what interactions people have when they take Abilify and Entyvio. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.

What is Entyvio?

Entyvio has active ingredients of vedolizumab. It is often used in crohn's disease. eHealthMe is studying from 23,827 Entyvio users. Check the latest studies of Entyvio.

On Jul, 16, 2026

34 people who take Abilify and Entyvio together, and have interactions are studied.

What are the common drug interactions of Abilify and Entyvio, by gender? *:

female:

Blood creatine phosphokinase increased
Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
Fatigue (feeling of tiredness)
Hypoaesthesia (reduced sense of touch or sensation)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Pulmonary embolism (blockage of the main artery of the lung)
Sensory loss (senses loss)
Pneumonia
Diarrhoea

male:

Pancreatic carcinoma (pancreatic cancer)
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
Dehydration (dryness resulting from the removal of water)
Cholecystitis chronic (long lasting infection of gallbladder)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Abdominal abscess (collection of pus in abdomen)
Abdominal adhesions (inflammation of abdomen)
Dilatation intrahepatic duct acquired
Gallbladder enlargement
Nephrolithiasis (calculi in the kidneys)

What are the common drug interactions of Abilify and Entyvio, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Hyperaesthesia

20-29:

Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Pulmonary embolism (blockage of the main artery of the lung)
Foot fracture
Nasopharyngitis (inflammation of the nasopharynx)
Pneumonia
Pulmonary oedema (fluid accumulation in the lungs)
Productive cough

30-39:

Blood creatine phosphokinase increased
Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
Fatigue (feeling of tiredness)
Hypoaesthesia (reduced sense of touch or sensation)
Sensory loss (senses loss)
Malaise (a feeling of general discomfort or uneasiness)
Diarrhoea
Mood altered (changes in mood)
Mouth ulceration (mouth ulcers)

40-49:

Abdominal distension
Constipation
Diarrhoea
Fatigue (feeling of tiredness)
Frequent bowel movements
General physical health deterioration (weak health status)
Insomnia (sleeplessness)
Myalgia (muscle pain)
Oedema peripheral (superficial swelling)
Pain in extremity

50-59:

Alopecia (absence of hair from areas of the body)
Bacterial infection
Conjunctivitis (pink eye)
Cystitis (inflammation of the wall of the bladder)
Dilatation intrahepatic duct acquired
Dysphagia (a condition in which swallowing is difficult or painful)
Dyspnoea (difficult or laboured respiration)
Flushing (the warm, red condition of human skin)
Fungal infection
Gallbladder enlargement

60+:

Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Pneumonia
Lung infection

What are the existing conditions these people have? *

Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 8 people, 23.53%
High Blood Pressure: 8 people, 23.53%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 23.53%
Rickets (softening of bones): 6 people, 17.65%
Kidney Stones: 5 people, 14.71%
Injection Site Rash: 5 people, 14.71%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 4 people, 11.76%
Insomnia (sleeplessness): 3 people, 8.82%
Blood Testosterone Decreased: 3 people, 8.82%
Bipolar Disorder (mood disorder): 3 people, 8.82%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Entyvio?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously